Health & Nutrition
Moderna shares plunge on plans to cut $1.1 billion in costs,...
Moderna is deprioritizing certain parts of its pipeline, which involves pausing...
Gilead's twice-yearly shot cut HIV infections by 96% in...
The data sets the stage for likely approval of Gilead's Lenacapavir for HIV prevention.
Creatinine to Normalize Homocysteine in Vegetarians?
What are the consequences of having to make your creatine rather than relying on...
Healthy Returns: More than 50 million privately insured...
A large swath of insured Americans could be eligible for a popular class of weight...
AstraZeneca shares fall 5% on disappointing lung cancer...
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in...
Testing for Vitamin B12 Deficiency
Many doctors mistakenly rely on serum B12 levels in the blood to test for vitamin...
Alzheimer's drug Leqembi promises to give patients more...
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties,...
Healthy Returns: Eli Lilly could soon become the first...
Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile,...
GE Healthcare shows signs of life, but a lingering uncertainty...
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon...
Abbott launches its first over-the-counter continuous glucose...
Abbott Laboratories announced Lingo, its first over-the-counter continuous glucose...
